SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001069530-19-000016
Filing Date
2019-03-27
Accepted
2019-03-27 15:02:30
Documents
5
Period of Report
2019-03-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ptie-20190327x8k.htm 8-K 38396
2 EX-3.1 ptie-20190327xex3_1.htm EX-3.1 269562
3 EX-3.2 ptie-20190327xex3_2.htm EX-3.2 14920
4 EX-99.1 ptie-20190327xex99_1.htm EX-99.1 32291
5 GRAPHIC ptie-20190327xex99_1g001.jpg GRAPHIC 5997
  Complete submission text file 0001069530-19-000016.txt   364914
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 19708098
SIC: 2834 Pharmaceutical Preparations